Exploring the time-dependent regulatory potential of microRNAs in breast cancer cells treated with proteasome inhibitors

ConclusionsThe diversity of pathways predicted to be affected by the diversity in miRNA expression after treatment with PIs paves the way for the recognition of new regulatory axes in BrCa.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research